Psilocybin Treatment for Addiction

Magic mushrooms: UAB Studying Benefits for Addiction and Pain

Psychedelic drugs creating hopes for breakthroughs in depression, anxiety, pain and addiction are being tested at UAB. The university is one of a handful in the nation conducting trials with psilocybin, the active ingredient in hallucinogenic mushrooms.


Vice News

Can 12 Step Groups and Psychedelic Addiction Treatment Coexist?

Psychedelic treatments for addiction challenge 12-step’s ideas about what sobriety is: total abstinence from any mood- or mind-altering drug—psychedelics included.

Source: Vice News

Johns Hopkins

Magic Mushrooms Help Longtime Smokers Quit

Johns Hopkins researchers report that a small number of longtime smokers who had failed many attempts to drop the habit did so after a carefully controlled and monitored use of psilocybin, the active hallucinogenic agent in so-called “magic mushrooms,” in the context of a cognitive behavioral therapy treatment program.

Source: Johns Hopkins

Scientific American

Johns Hopkins Scientists Give Psychedelics the Serious Treatment

Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look. Scientists are rediscovering what many see as the substances’ astonishing therapeutic potential for a vast range of issues, from depression to drug addiction and acceptance of mortality.

Source: Scientific American